Labcorp announces 2023 fourth quarter and full year results

Company provides 2024 guidance results from continuing operations for the fourth quarter and full year versus last year: revenue: q4 of $3.03 billion vs $2.93 billion; full year of $12.16 billion vs $11.86 billion diluted eps: q4 of $(1.95) vs $0.42 ; full year of $4.33 vs $10.94 adjusted eps: q4 of $3.30 vs $3.05 ; full year of $13.56 vs $16.66 free cash flow: q4 of $414.2 million vs $508.1 million; full year of $748.7 million vs $1.34 billion announced six new laboratory partnerships and launched new innovative tests in our focused specialty areas across the business in 2023 full year 2024 guidance: adjusted eps of $14.30 to $15.40 and free cash flow of $1.00 billion to $1.15 billion burlington, n.c. , feb. 15, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter and year ending dec. 31, 2023, and full year 2024 guidance.
LH Ratings Summary
LH Quant Ranking